Lately it has come to our attention that kratom (MITRAGYNA SPECIOSA) is being targeted more frequently in the past couple of months. Specifically, U.S. Customs and Border Protection ("Customs" or "CBP") and the U.S. Food and Drug Administration ("FDA") have been examining and detaining kratom shipments from overseas. Additionally, express consignment operators such as FedEx, UPS, and DHL, are cautious to ship the product because of the potential problems associated with this botanical. These delays can be attributed to FDA's import alert 54-15. The alert provides for: DETENTION WITHOUT PHYSICAL EXAMINATION OF DIETARY[...]
DISCLAIMER: The content of this website has been prepared by the Abady Law Firm, P.C., for informational purposes only and should not be construed as legal advice. The material posted on this website is not intended to create, and receipt of it does not constitute, a lawyer-client relationship, and readers should not act upon it without seeking professional counsel. The Abady Law Firm, P.C., did not produce and is not responsible for the content of off-site legal resources. The materials on this site may constitute advertising under various state ethics rules.